On Oct 2, 2026, a WARN notice revealed AssistRx will cut 86 workers at its CoAssist Pharmacy at 2400 Sand Lake Road starting Nov 30, with 137 more cuts staged between Jan 4 and May 2027. If you are one of the 57 techs, 13 pharmacists, 5 supervisors, 5 warehouse ops, 3 CoAssist program managers, the call center director, the ops coordinator, or the pharmacy program trainer, you have roughly six weeks before an identical second cohort floods LinkedIn with your exact job titles.
The resume that gets you out of this cleanly is not a "pharmacy tech" resume. It is a hub-services resume, and almost nobody writes one correctly.
Why "Pharmacy Technician" is the wrong headline keyword
Leading with "Pharmacy Technician" drops you into a 90,335-person US pool dominated by CVS Health and Walgreens retail dispensing, where your CoAssist skills are invisible and the pay floor is lower than your $21 to $24 per hour anchor at Sand Lake. The scarce, better-paid lane is the hub-services and patient-access niche where AssistRx itself ranks as a top employer, and only about 41 US profiles explicitly brand themselves that way.
That gap matters because recruiters at ConnectiveRx, CareMetx, and EVERSANA are not boolean-searching "pharmacy technician." They are searching for the exact service surface they are trying to staff: eBV, ePA, eConsent, eEnrollment, Advanced Benefit Verification, EHR-integrated intake. If those strings are missing from your resume, you do not exist to them. If they are present and quantified, you are one of maybe forty people in the country who looks like a fit.
In Refolk's index, the actual addressable niche the 86 CoAssist workers should target.
The segments, side by side
| Segment | US headcount (Refolk index) | Top employer signal | What it means for you |
|---|---|---|---|
| Pharmacy Technician (title) | 90,335 | CVS Health, Walgreens, Mixlab | Broad floor, retail-dominated, 57 AssistRx techs are 0.06% of the pool |
| Patient Access Specialist (title) | 9,285 | Emerus, St. Luke's, Syneos Health | Hospital-side intake, pays less, uses none of your eBV/ePA muscles |
| Hub services / patient access / specialty pharmacy (keyword) | 41 | AssistRx, IQVIA, Takeda, Blueprint Medicines, Nestlé Health Science | The real addressable niche, AssistRx is a top employer in it |
| Greater Orlando share of the hub-services niche | 2 of 41, roughly 4.9% | AssistRx | Orlando is roughly 7x overrepresented vs its population share |
What recruiters at ConnectiveRx and CareMetx actually want to see
The four strings that make a CoAssist resume readable to a hub competitor are eBV, ePA, eConsent, and eEnrollment, with CoAssist and Advanced Gateway named explicitly in the first 200 words. Those are the e-Support Services surface the industry buys, and they are what every competing hub lists in its own job descriptions.
Order the bullets so the top of each role answers four questions a hub recruiter is scanning for:
- What program and therapeutic area did you support? Rare disease, oncology, specialty injectable, GLP-1. Name it.
- Which electronic workflows did you own? ePA, eBV, eConsent, eEnrollment, Advanced Benefit Verification, eIncome Verification, reverification automation.
- What EHR integrations did you touch? Allscripts was AssistRx's 2016 anchor partnership for direct EHR-integrated specialty prescribing. Epic, Cerner, athenahealth if you touched them.
- What speed or revenue number can you cite? This is where CoAssist alumni have published ammunition most peers do not.
Rewriting every bullet against each posting is tedious work when you have 60 applications to send in six weeks. It is also the exact work Refolk takes off you: paste the ConnectiveRx or CareMetx posting, get your own resume back rewritten against its language, with a fit score telling you which postings are worth the cover letter and which are a waste.
The three CoAssist program managers are the most portable, not the pharmacists
If you are one of the three CoAssist program managers being cut, you own the most portable resume in the building, because the speed and revenue numbers AssistRx has published about CoAssist are yours to quote. Pharmacists have state licensure that re-routes them cleanly, but program managers compete in a national hub-services PM market where published benchmarks are the entire interview.
Two numbers belong at the top of your resume:
- 12.2 days to 3.7 days from prescription to therapy, a roughly 70% reduction, achieved by a manufacturer using CoAssist. On the same implementation, 50% of PA decisions returned within one hour and 70% same day.
- 115 patients converted to commercial therapy and roughly $16 million in recaptured revenue from automating reverification with Advanced Benefit Verification and eIncome Verification.
Those are published benchmarks, not trade secrets. ConnectiveRx, CareMetx, and EVERSANA sell against exactly those metrics, and a resume that opens with "led CoAssist program delivery that cut prescription-to-therapy from 12.2 to 3.7 days" is a different document than one that opens with "managed hub services team of 14." The second is a job description. The first is a sales pitch to the person reading it.
Program managers who do not quote the 12.2 to 3.7 day number are leaving the strongest line on their resume in the clickorlando.com archive.
If you also had any exposure to AllazoHealth, AssistRx's 2025 AI patient-engagement acquisition, that goes in the summary. Every hub competitor is trying to bolt an engagement and adherence layer onto their offering, and candidates who can speak to engagement analytics on top of hub operations are rare.
The pivot targets, in order
The right first call list is other hubs, then pharma manufacturer patient-services teams, then PBMs, in that order. Hospital-side patient access is a trap for most of this cohort.
Competing hubs (first wave)
- ConnectiveRx
- CareMetx
- EVERSANA
- Lash Group (Cencora)
- PHIL Inc., whose PHIL Direct product launched September 2025
These five hire for the exact service surface you already run. Your resume to them should barely need translation, which means it will barely need translation only if the surface strings are present verbatim.
Pharma manufacturers with patient-services teams
Refolk's index surfaces active hub-services and patient-access staffing at:
- Takeda
- Blueprint Medicines
- Acadia Pharmaceuticals
- Nestlé Health Science
- Priovant Therapeutics
- Veloxis Pharmaceuticals
- Curium Pharma
Manufacturer patient-services roles pay more than hospital patient access, keep you on the manufacturer-funded program side of the aisle (where your reimbursement fluency compounds), and often go remote.
Why the hospital "Patient Access Specialist" pivot is a trap
The 9,285-profile Patient Access Specialist pool is dominated by Emerus Holdings, St. Luke's, and University Hospitals, which is provider-side registration and intake. It pays less, it does not touch manufacturer-funded programs, and none of the eBV, ePA, Advanced Gateway, or reverification muscles AssistRx built on you convert. A pharmacist taking a hospital intake role to stop the income bleed is losing roughly two years of career momentum to save three months of search time. The number may still make sense for some. Go in with eyes open.
Orlando is not a dead zone, which changes the geography of the search
Greater Orlando is tied with Greater Boston and Greater Tampa Bay as the top metro for self-identified hub-services profiles in Refolk's index, which means relocation is optional, not required. Two of the forty-one profiles are already in Orlando, roughly 4.9% of a niche whose population share should be closer to 0.7%, a 7x concentration.
In Refolk's index, Orlando ties Boston and Tampa Bay as the #1 metro for the niche.
Mechanically, this means three things:
- Local manufacturer field-access roles are geographically plausible without a move.
- Remote PBM and hub roles will treat your Orlando address neutrally, because the recruiter has already placed candidates there.
- The in-person pivot event, the Asembia Specialty Pharmacy Summit, is the industry's main hiring and networking venue, referenced in AssistRx's own CoAssist marketing. If the next edition falls inside your severance window, go.
The other shoe in the local market is Hancock Whitney eliminating 52 Orlando positions in December. Orlando's hiring pipelines are absorbing two simultaneous shocks, which is a reason to move early, not a reason to despair. Hancock Whitney is a different pool.
The 137 follow-on cuts may never generate a second WARN
Florida has no state WARN layer, so if AssistRx stages the Jan to May 2027 cuts below the federal 50-worker or 33% site trigger, no second public filing will appear. That gives the Nov 30 cohort a roughly six-week head-start window before an invisible second wave hits LinkedIn with identical titles.
Practically:
- Weeks 1 to 2 (now through mid-November). Rewrite the resume. Lead with CoAssist, eBV, ePA, Advanced Gateway, EHR integration. Quote the 12.2 to 3.7 day and $16M numbers if you can defend them. Open a dedicated search inbox.
- Weeks 3 to 6 (through end of year). Apply to ConnectiveRx, CareMetx, EVERSANA, Lash Group, PHIL Inc. first. Then Takeda, Blueprint, Acadia, Nestlé Health Science, Priovant, Veloxis, Curium. Tailor every application. Refolk writes the resume from your own history, tailors it to each posting, drafts the cover letter, and scores how well you actually fit before you spend the cover-letter time.
- January onward. Expect a second wave of resumes with your exact titles whether or not a second WARN appears. By then your interviews should already be scheduled.
Severance, references, and the "permanent" language
AssistRx told affected staff that "these separations are expected to be permanent." That is useful phrasing for your own narrative, because it closes off the "returning to the role" question in interviews and lets you talk about CoAssist as a completed body of work with published outcomes rather than a job you are hoping to get back. Line up two references now: one supervisor who can speak to program delivery, one peer who can speak to day-to-day eBV or ePA execution. Reference checks are where offers die at this level.
FAQ
Should I list "CoAssist" by name on my resume if I am applying to ConnectiveRx or CareMetx?
Yes. CoAssist is a named, publicly marketed platform with published performance benchmarks, not a proprietary secret, and the recruiter at a competing hub recognizes it instantly. Naming it signals that you have worked on EHR-integrated electronic intake at scale, not just dispensing. Pair it with the service strings those competitors use in their own postings (eBV, ePA, eConsent, Advanced Benefit Verification) so the ATS has something to match against.
Can I quote the 12.2 to 3.7 day number if I was not personally the program lead?
Only if you can defend your contribution to it in an interview. The number is public, so quoting it is not a disclosure risk, but a hiring manager will ask what you specifically did. If you were on the implementation, say "contributed to." If you were adjacent, cite it as a program benchmark you supported rather than one you led. Overclaiming a number this specific is how offers get pulled during reference checks.
Is a hospital Patient Access Specialist role a reasonable fallback?
For pharmacy techs and the ops coordinator, sometimes yes. For pharmacists and the three CoAssist program managers, almost never, because the pay and the skill utilization both drop sharply and you leave the manufacturer-funded-program side of the industry where your experience compounds. If cash flow forces it, treat it as a 6-month bridge and keep applying to hubs and manufacturers through it.
Do I need to attend Asembia to get hired?
No, but if the next edition falls inside your severance window and you are a program manager, supervisor, or director-level candidate, going is the single highest-leverage week you can spend. Hub-services hiring is a small, relationship-driven market. Forty-one self-identified profiles nationally means the people doing the hiring largely know each other, and showing up in person moves you from a resume in a pile to a person they met.